Research ArticleOriginal Research
The Role of Suboptimal Concentrations of Nebulized Tobramycin in Driving Antimicrobial Resistance in Pseudomonas aeruginosa Isolates in Cystic Fibrosis
John E Moore, B Cherie Millar, Marika Ollman-Selinger and Lisa Cambridge
Respiratory Care July 2021, respcare.08671; DOI: https://doi.org/10.4187/respcare.08671
John E Moore
Northern Ireland Public Health Laboratory, Belfast City Hospital, Belfast, Northern Ireland, United Kingdom.
B Cherie Millar
Northern Ireland Public Health Laboratory, Belfast City Hospital, Belfast, Northern Ireland, United Kingdom.
Marika Ollman-Selinger
Pari GmbH, Starnberg, Germany.
Lisa Cambridge
Pari Respiratory Equipment, Midlothian, Virginia.
In this issue
Respiratory Care
Vol. 69, Issue 12
1 Dec 2024
The Role of Suboptimal Concentrations of Nebulized Tobramycin in Driving Antimicrobial Resistance in Pseudomonas aeruginosa Isolates in Cystic Fibrosis
John E Moore, B Cherie Millar, Marika Ollman-Selinger, Lisa Cambridge
Respiratory Care Jul 2021, respcare.08671; DOI: 10.4187/respcare.08671